Related Experiment Video
Updated: Aug 8, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Abstract:
Prostatic cancer is a common cause of morbidity and mortality in the United States. Although many new serologic and radiologic procedures are now used in its diagnosis, the rectal examination still remains the best diagnostic test. Staging is essential for effective treatment. Treatment of prostatic cancer varies, with observation in stage A1; surgery and/or irradiation for stages A2, B, and C; and hormonal or cytotoxic drugs for symptomatic stage D.

